Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:12/5/2018)... ... December 05, 2018 , ... Northcentral University (NCU) has ... nursing. Available starting today and on a weekly rolling basis to registered nurses, the ... Practice in Executive Leadership (DNP) will prepare degree candidates to become leaders in ...
(Date:12/5/2018)... ... , ... Domenic Palmieri has been named chief operating officer ... for the executive oversight of operations for three core divisions within HM, including ... position,” Tom Doran, president, HM Insurance Group, said. “And while we had significant ...
(Date:12/5/2018)... ... December 04, 2018 , ... Earthly Mist, Edmond, Oklahoma’s ... 4th Street. , The dispensary will serve Edmond, Oklahoma residents who present a ... patients to find the correct medical cannabis product based on their doctor’s recommendations. ...
(Date:12/5/2018)... ... 05, 2018 , ... Definitive Healthcare , the leading ... that it was ranked #184 on Deloitte’s Technology Fast 500 list for 2018. ... the fields of technology, media, telecommunications, life science, and energy tech companies from ...
(Date:11/29/2018)... ... , ... The National Association of Chronic Disease Directors (NACDD) ... Chronic Disease is Essential - Prevention Works ,” to support federal funding for ... , The paper outlines some of the strongest public health, economic, and societal ...
Breaking Medicine News(10 mins):
... Strategy and Design, NEW YORK, May 19 ... to develop a new web site strategy and ... Health, one of the world,s,leading research, education, and ... issues., "The Mailman website provides a vast ...
... are using,employee cost sharing, eligibility audits, spousal and smoker ... hold the line ... 19 McGraw Wentworth, Michigan,s,largest employee group benefit brokerage/consulting ... Mid-Market Group Benefits,Survey. The 2008 Mid-Market Group Benefit Survey ...
... finds them sooner, could cut unnecessary surgeries , , ... for the presence of a lectin molecule called galectin-3 ... reduce the number of unnecessary surgeries, according to an ... whether a nodule is malignant is to examine cells ...
... used in traditional medicine by many Middle Eastern countries ... of the most difficult cancers to treat. Researchers at ... that thymoquinone, an extract of nigella sativa seed oil, ... by enhancing the process of programmed cell death. ...
... Record Revenue and Gross Margin Performance - ... ... PLYMOUTH MEETING, Penn., May 19 /Xinhua-PRNewswire-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP ... first quarter of 2008. The,Company intends to file its Form 10Q today., ...
... May 19 Environmental,Tectonics Corporation,s (Amex: ETC ... announced the sale and installation of two (2),BARA-MED(R) ... for,placement at one of the many Innovations Healthcare ... work with Innovations Healthcare Consulting, a,growing company who ...
Cached Medicine News:
(Date:12/5/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD ... Integration at the United States Pharmacopeial Convention (USP), has joined the firm as ... in domestic and international operations harmonization, compendial affairs, and the development and management ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for ... the launch of the Annatto-E™ product line, containing unique and natural vitamin E ... research, DFH’s new Annatto-E™ products are available in three dosages of 75mg (with ...
(Date:11/29/2018)... NORTH HOLLYWOOD, Calif. (PRWEB) , ... November 29, 2018 , ... ... and rehabilitation center located in North Hollywood, CA, announced today they were selected ... in California to participate in a new Volunteer Engagement Project. , The California ...
Breaking Medicine Technology:
... leading provider of healthcare analytics and predictive modeling for ... Ian McGuinness to the position of Vice President, Business ... Ian to our team as we continue adding senior-level ... business," said Al Reicheg, Chief Commercial Officer of Qforma.  ...
... 19, 2011  Medical Alarm Concepts Holding, Inc. (OTCQ:MDHI), ... alarm system that allows you to speak and ... plans to promote the MediPendant™  utilizing an ecommerce ... its members. Costco is the ...
Cached Medicine Technology: